Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05440864 |
| Title | Durvalumab and Tremelimumab in Resectable HCC ((NEOTOMA)) |
| Acronym | (NEOTOMA) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University Health Network, Toronto |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA | ESP | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University Health Network | RECRUITING | Toronto | Ontario | M5G 2M9 | Canada | Details |
| University of Milan | NOT_YET_RECRUITING | Milan | 20122 | Italy | Details | |
| Clinica Universidad De Navarra | NOT_YET_RECRUITING | Pamplona | 31008 | Spain | Details |